Vantage Pharma – Medical Alley Association

Vantage Pharma

EP Vantage Pharma & Medtech 2017 Review

In the early weeks of 2017 biopharma investors were preoccupied with working out whether the year would head up or down. Put generously, 2016 had been flat, and hopes were high that the months ahead would see a recovery. On most measures, 2017 delivered a resurgence. And the picture was similar for the medical technology industry, though life got […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER